Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Inclusion Criteria:

• Those who participated in the K0106 clinical trial and received FURESTEM-AD Inj
• Those who understand and voluntarily sign an informed consent form

Exclusion Criteria:

• None